STACEY L EPPS
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- MECHANICSVILLE, VA
- NPI
- 1154391571
- Received
- $108,864 in 1,268 records, 2019 to 2025
- Person page
- STACEY L EPPS Fuzzy (full name with a middle part, and the recipient's state)
- Source
- CMS Open Payments search ↗
On this site
- Person page: Stacey L Epps MD Fuzzy (same full name with a middle name or initial, one person page, in that person's states)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 79 | $33,867 |
| 2024 | General payment | 117 | $12,612 |
| 2023 | General payment | 182 | $3,924 |
| 2022 | General payment | 201 | $9,144 |
| 2021 | General payment | 236 | $14,773 |
| 2020 | General payment | 148 | $6,851 |
| 2019 | General payment | 305 | $27,691 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 37 | $52,284 |
| Food and Beverage | 1,187 | $23,851 |
| Consulting Fee | 6 | $14,300 |
| Compensation for serving as faculty or as a speaker for a medical education program | 13 | $12,232 |
| Travel and Lodging | 18 | $5,742 |
| Education | 7 | $454 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Biogen, Inc. | $17 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-12-18 | Janssen Biotech, Inc. | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-18 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-17 | Neurelis, Inc. | $17 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-12-16 | Lilly USA, LLC | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-12-16 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-12-16 | UCB, Inc. | $4 | Food and Beverage | In-kind items and services | Nayzilam Drug, Neurology | 2025 | |
| 2025-12-11 | Lilly USA, LLC | $124 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-12-06 | UCB, Inc. | $71 | Food and Beverage | In-kind items and services | Nayzilam Drug, Neurology | 2025 | |
| 2025-12-01 | Lilly USA, LLC | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-12-01 | Lilly USA, LLC | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-25 | UCB, Inc. | $3 | Food and Beverage | In-kind items and services | Nayzilam Drug, Neurology | 2025 | |
| 2025-11-20 | Lilly USA, LLC | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-20 | Lilly USA, LLC | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-20 | Lilly USA, LLC | $120 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-19 | Lundbeck LLC | $119 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-11-18 | Biogen, Inc. | $18 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-11-18 | UCB, Inc. | $5 | Food and Beverage | In-kind items and services | Nayzilam Drug, Neurology | 2025 | |
| 2025-11-13 | Lilly USA, LLC | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-13 | Lilly USA, LLC | $58 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-12 | Lilly USA, LLC | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-12 | Lilly USA, LLC | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-12 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-11-11 | Eisai Inc. | $1,300 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-06 | Lilly USA, LLC | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-06 | Lilly USA, LLC | $64 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-28 | Lilly USA, LLC | $10 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2025 | |
| 2025-10-24 | Lilly USA, LLC | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-10-09 | Biogen, Inc. | $17 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2025 | |
| 2025-10-07 | Lilly USA, LLC | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-10-07 | Lilly USA, LLC | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-10-02 | Lilly USA, LLC | $124 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-26 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2025 | |
| 2025-09-17 | Alexion Pharmaceuticals, Inc. | $134 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-09-10 | Eisai Inc. | $1,300 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-10 | Eisai Inc. | $520 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-10 | Eisai Inc. | $122 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-09 | Lilly USA, LLC | $4,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-02 | LivaNova USA, Inc. | $15 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2025 | |
| 2025-07-15 | UCB, Inc. | $9 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-07-09 | Medtronic, Inc. | $67 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-06-17 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-06-17 | UCB, Inc. | $6 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-06-04 | UCB, Inc. | $2 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-06-03 | UCB, Inc. | $20 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-05-20 | Eisai Inc. | $612 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-20 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-05-19 | Eisai Inc. | $245 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-13 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2025 | |
| 2025-04-29 | MicroTransponder, Inc. | $24 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-04-29 | Biogen, Inc. | $16 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2025 | |
| 2025-04-22 | UCB, Inc. | $11 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-04-16 | Eisai Inc. | $1,225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-16 | Eisai Inc. | $490 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-16 | Eisai Inc. | $121 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-15 | SK Life Science, Inc. | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-01 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-03-27 | Lilly USA, LLC | $120 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-03-25 | UCB, Inc. | $21 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-03-20 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-03-20 | LivaNova USA, Inc. | $42 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2025 | |
| 2025-03-11 | MDD US Operations, LLC | $17 | Food and Beverage | In-kind items and services | Gocovri Drug, AMANTADINE | 2025 | |
| 2025-03-04 | C2N Diagnostics, LLC | $16 | Food and Beverage | In-kind items and services | PRECIVITYAD2 Device, ALZHEIMER'S DISEASE | 2025 | |
| 2025-02-26 | Eisai Inc. | $725 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-02-25 | Eisai Inc. | $1,470 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-02-25 | Eisai Inc. | $1,225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-02-25 | Eisai Inc. | $125 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-02-25 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-02-18 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2025 | |
| 2025-02-04 | Eisai Inc. | $1,225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-02-04 | Eisai Inc. | $490 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-02-04 | Eisai Inc. | $103 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-01-30 | UCB, Inc. | $18 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-01-29 | SK Life Science, Inc. | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-28 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-01-28 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-01-14 | UCB, Inc. | $6 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2025 | |
| 2025-01-07 | Eisai Inc. | $980 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2024-12-17 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-12-17 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-12-16 | UCB, Inc. | $6 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-12-10 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-12-05 | Genentech USA, Inc. | $13 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2024 | |
| 2024-11-20 | ABBVIE INC. | $53 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-11-20 | Neurelis, Inc. | $16 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-11-19 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-11-19 | Celgene Corporation | $12 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-11-18 | Eisai Inc. | $23 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-11-08 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-11-07 | UCB, Inc. | $32 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-10-29 | UCB, Inc. | $20 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2024 | |
| 2024-10-28 | Genentech USA, Inc. | $19 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2024 | |
| 2024-10-19 | LivaNova USA, Inc. | $35 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2024 | |
| 2024-10-18 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-10-17 | Neurelis, Inc. | $11 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-10-16 | Neurelis, Inc. | $16 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-10-15 | Eisai Inc. | $980 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-10-15 | Eisai Inc. | $14 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-10-09 | Alexion Pharmaceuticals, Inc. | $100 | Education | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-10-08 | Lilly USA, LLC | $121 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2024 | |
| 2024-10-03 | UCB, Inc. | $32 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-10-01 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-25 | Boston Scientific Corporation | $150 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-09-24 | Celgene Corporation | $8 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-09-23 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-09-20 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-09-18 | Lundbeck LLC | $81 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-09-18 | Lundbeck LLC | $28 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-09-17 | Biogen, Inc. | $15 | Food and Beverage | In-kind items and services | LEQEMBI Drug, Neurology | 2024 | |
| 2024-09-17 | UCB, Inc. | $7 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-09-12 | Eisai Inc. | $1,225 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-09-12 | Eisai Inc. | $490 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-09-12 | Eisai Inc. | $95 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-09-11 | Neurelis, Inc. | $16 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-09-10 | Biogen, Inc. | $18 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2024 | |
| 2024-09-10 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-06 | LivaNova USA, Inc. | $37 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2024 | |
| 2024-08-29 | Celgene Corporation | $10 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-08-28 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-08-27 | Boston Scientific Corporation | $140 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-08-22 | Eisai Inc. | $26 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-08-16 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-08-14 | UCB, Inc. | $8 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-08-06 | UCB, Inc. | $13 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-07-31 | Neurelis, Inc. | $12 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-07-30 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-26 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-07-25 | UCB, Inc. | $34 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-07-22 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-07-19 | Eisai Inc. | $6,040 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-07-19 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-07-16 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-07-10 | CATALYST PHARMACEUTICALS, INC. | $16 | Education | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2024 | |
| 2024-06-27 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-26 | Neurelis, Inc. | $15 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-06-22 | Eisai Inc. | $74 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $53 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $49 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $47 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $36 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $17 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $16 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-22 | Eisai Inc. | $12 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-21 | Eisai Inc. | $342 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-21 | Eisai Inc. | $222 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-21 | Eisai Inc. | $107 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-21 | Eisai Inc. | $63 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-06-21 | Eisai Inc. | $16 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-05-21 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-05-17 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-05-16 | Neurelis, Inc. | $12 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-05-15 | Neurelis, Inc. | $97 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-05-15 | Lundbeck LLC | $14 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-05-14 | Eisai Inc. | $4 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-05-10 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-04-26 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-04-25 | UCB, Inc. | $8 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-04-19 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-04-19 | Eisai Inc. | $23 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-04-18 | SK Life Science, Inc. | $18 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-16 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-04-15 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-04-12 | CSL Behring | $17 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2024 | |
| 2024-04-11 | UCB, Inc. | $42 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-03-29 | Neurelis, Inc. | $13 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-03-21 | LivaNova USA, Inc. | $22 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2024 | |
| 2024-03-20 | SK Life Science, Inc. | $123 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-03-20 | UCB, Inc. | $17 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-03-20 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-03-19 | Eisai Inc. | $6 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-03-15 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-03-14 | UCB, Inc. | $13 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-03-14 | Neurelis, Inc. | $12 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-03-07 | UCB, Inc. | $25 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-02-29 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-02-23 | Celgene Corporation | $12 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-02-22 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2024 | |
| 2024-02-21 | Eisai Inc. | $121 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2024 | |
| 2024-02-21 | CSL Behring | $14 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2024 | |
| 2024-02-20 | UCB, Inc. | $5 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-02-16 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-02-10 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2024 | |
| 2024-02-07 | LivaNova USA, Inc. | $29 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Neurology | 2024 | |
| 2024-02-06 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-02-06 | UCB, Inc. | $24 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2024 | |
| 2024-01-31 | UCB, Inc. | $29 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-01-24 | Neurelis, Inc. | $16 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-01-19 | UCB, Inc. | $16 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-01-19 | UCB, Inc. | $2 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-01-17 | TG Therapeutics, Inc. | $85 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2024 | |
| 2024-01-17 | SK Life Science, Inc. | $13 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-16 | Eisai Inc. | $6 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-01-11 | Celgene Corporation | $7 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-01-03 | UCB, Inc. | $7 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2024 | |
| 2024-01-02 | Biogen, Inc. | $13 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2024 | |
| 2023-12-15 | LivaNova USA, Inc. | $25 | Food and Beverage | In-kind items and services | VNS THERAPY SENTIVA MODEL 1000 GENERATOR Device, Cardiology/Vascular Diseases | 2023 | |
| 2023-12-14 | Eisai Inc. | $21 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2023 | |
| 2023-12-13 | UCB, Inc. | $10 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2023 | |
| 2023-12-12 | Celgene Corporation | $7 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 |
The latest 200 records of 1,268.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Mechanicsville, VA, county Hanover County, VA, state Virginia; placed by its city name.
| Measure | Place (city or town) Mechanicsville, VA | County Hanover County, VA | State Virginia |
|---|---|---|---|
| Population B01003 | 38,683 | 112,879 | 8,705,170 |
| Population, 2020 census P1 | 39,482 | 109,979 | 8,631,393 |
| Median age B01002 | 41.8 | 42.7 | 39.0 |
| Under 18 B01001 | 21.8% | 21.6% | 21.7% |
| 65 and over B01001 | 19.8% | 19.2% | 16.7% |
| Households B11001 | 15,337 | 42,688 | 3,365,732 |
| Foreign born B05002 | 3.8% | 4.3% | 13.1% |
| Median household income B19013 | $98,595 | $112,805 | $93,170 |
| Median family income B19113 | $120,441 | $132,791 | $115,213 |
| Per capita income B19301 | $45,231 | $53,490 | $50,666 |
| Poverty rate B17001 | 5.2% | 5.7% | 9.9% |
| Unemployment rate B23025 | 1.9% | 2.7% | 4.3% |
| Civilian labor force B23025 | 20,438 | 60,013 | 4,468,236 |
| Mean commute (minutes) B08013 | 23.9 | 26.9 | 27.3 |
| Bachelor's degree or higher B15003 | 35.8% | 42.7% | 42.2% |
| Housing units B25001 | 15,947 | 44,589 | 3,684,756 |
| Owner-occupied B25003 | 75.5% | 82.1% | 67.3% |
| Renters B25003 | 24.5% | 17.9% | 32.7% |
| Median home value B25077 | $351,000 | $400,400 | $383,700 |
| Median gross rent B25064 | $1,724 | $1,591 | $1,579 |
| White, not Hispanic B03002 | 82.3% | 80.7% | 58.4% |
| Black B03002 | 8.2% | 8.3% | 18.3% |
| Hispanic or Latino B03002 | 2.8% | 4.0% | 11.0% |
| Asian B03002 | 1.5% | 2.1% | 6.9% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Mechanicsville, VA.
Comments